Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Paracetamol + Caudal Ropivacaine in Hypospadias Repair
NCT03781505Phase 4Completed
- Sponsor
- Aga Khan University
- Start
- Jan 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing IV Paracetamol + Caudal Ropivacaine with Placebo + Caudal Ropivacaine (2 arms). Primary endpoint: Postoperative Analgesia Requirement at 6 hours. Started Jan 2019; status: completed.
02
Drugs
acetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03781505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781505.